Literature DB >> 581134

EOG in a large family with hereditary macular degeneration. (Best's vitelliform macular dystrophy) identification of gene carriers.

W Thorburn, S Nordström.   

Abstract

A total of 128 descendants from one large family with a history of hereditary macular degeneration (HMD) were examined with EOG. Of these, 42 were affected patients, 48 were healthy offsprings to affected parents, and 38 were normal controls. Affected subjects had a light peak/dark trough ratio smaller than 1.40. In the group of offspring of affected parents the Lp/DT ratios showed a bimodal distribution dividing the group into two parts, one with values less than 1.40 and another with values larger than 1.70. Thus carriers of the HMD gene can apparently be identified by use of EOG. The affected subjects and the carriers had a lower base value of the standing potential than the controls.

Entities:  

Mesh:

Year:  1978        PMID: 581134     DOI: 10.1111/j.1755-3768.1978.tb05699.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

Review 1.  Electrophysiology and inherited retinal disorders.

Authors:  G A Fishman
Journal:  Doc Ophthalmol       Date:  1985-08-30       Impact factor: 2.379

Review 2.  A meta-analysis of clinical electro-oculography values.

Authors:  Paul A Constable; David Ngo; Stephen Quinn; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2017-10-10       Impact factor: 2.379

3.  Light and alcohol evoked electro-oculograms in cystic fibrosis.

Authors:  Paul A Constable; John G Lawrenson; Geoffrey B Arden
Journal:  Doc Ophthalmol       Date:  2006-10-05       Impact factor: 2.379

Review 4.  Functional roles of bestrophins in ocular epithelia.

Authors:  Alan D Marmorstein; Harold E Cross; Neal S Peachey
Journal:  Prog Retin Eye Res       Date:  2009-05-04       Impact factor: 21.198

5.  Local macular ERG in patients with Best's disease.

Authors:  M Horiguchi; Y Miyake; K Yagasaki
Journal:  Doc Ophthalmol       Date:  1986-11-15       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.